Australia markets open in 1 hour 17 minutes

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.96+1.30 (+6.97%)
At close: 04:00PM EST
20.00 +0.04 (+0.20%)
After hours: 04:08PM EST
Full screen
Loading interactive chart…
  • Motley Fool

    Anavex Life Sciences (AVXL) Q4 2021 Earnings Call Transcript

    With us today is Dr. Christopher Missling, president and chief executive officer; and Sandra Boenisch, principal financial officer. Following management's remarks, there will be a question-and-answer session.

  • GlobeNewswire

    Anavex Life Sciences to Present at the 4th Annual Evercore ISI HealthCONx Conference

    NEW YORK, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that its President and Chief Executive Officer, Christopher U. Missling, PhD, is scheduled to partic

  • GlobeNewswire

    Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results

    Webcast and Conference Call Today at 4:30 p.m. Eastern TimeNEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for its fiscal year ende